Baidyanath Avipattikar Churna neutralizes the acid secretion in the gastrointestinal tract and promotes the production of digestive enzymes which aid in the absorption of nutrients. Hence, it is known for its antacid activity. Avipattikar churna possesses strong carminative, antioxidant and anti-inflammatory properties that aid in curing imbalance related to Pitta dosha. The unique combination of 14 proven herbs to improve the functioning of the digestive system.
Special Features:
- Ayurvedic remedy for indigestion and bowel problems
- Soothes stomach pain, gastritis and vomiting
- Treats acidity by balancing pH levels
- Promotes healthy liver function
- Helps fortify the immune system
About the Brand:Â Shree Baidyanath Ayurved Bhawan Pvt. Ltd., popularly known as Baidyanath, is the leader of Ayurvedic know-how. Established in 1917, the company was founded by late Pt. Ram Dayal Joshi with a vision of providing effective and readily available medicines to the population of India. Baidyanath has played a pioneering role in re-establishing ancient knowledge with modern research and manufacturing techniques to provide the gentle healing touch of Ayurveda to millions around the world. Today, the product range has 700 products along with natural products. It comprises of single and patented herb supplements, oils, herbal juices as well as classical Ayurvedic medicines. These products provide the much needed nutrition and contribute to a healthy life to the consumers in order to succeed in the long run.
How To Use:
Recommended dosage:Â 1-2 teaspoonful twice a day with water or as advised by the physician.
Note: Ayurvedic medication should always be taken in a recommended doses and for a recommended duration under an Ayurvedic doctor supervision. Self medication of this medicine is not advised.
Storage information:Â Store in a cool place in tightly closed bottle, protected from light and moisture.
Country of Origin: India
Additional information
Brand | Baidyanath |
---|---|
Size | 120g, 60g |
Reviews
There are no reviews yet.